Form 4: Ekso Bionics Director Deborah Lafer Scher Acquires Restricted Stock Units
SEC Form 4 Filing
Director Deborah Lafer Scher acquired 236,202 restricted stock units in Ekso Bionics Holdings, Inc., increasing her total holdings to 314,419 shares.
Summary
- On May 16, 2025, Deborah Lafer Scher, a director of Ekso Bionics Holdings, Inc., acquired 236,202 restricted stock units (RSUs).
- The RSUs were granted effective May 16, 2025, pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021.
- Each RSU represents the economic equivalent of one share of EKSO common stock and will be settled in shares of EKSO common stock upon vesting.
- The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.
- Following the transaction, Scher beneficially owns 314,419 shares of common stock, including 236,202 unvested RSUs.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and alignment of director interests with shareholders.
Positives
- The acquisition of RSUs by a director signals confidence in the company's future prospects.
- The automatic annual non-employee director grant provision aligns director interests with shareholder value.
Future Outlook
The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.
Industry Context
This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Automatic Annual Non-Employee Director Grant Provision | The RSUs were granted pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. | 2021-04-13 | This provision ensures consistent compensation for non-employee directors and aligns their interests with the company's long-term success. |
Stakeholder Impact
- Shareholders: The grant of RSUs aligns director interests with shareholder value.
- Directors: The RSUs provide additional compensation and incentivize directors to contribute to the company's success.
Key Dates
| Date | Description |
|---|---|
| 2021-04-13 | Date the Company's Board of Directors approved the automatic annual non-employee director grant provision. |
| 2025-05-16 | Date of the Issuer's 2025 Annual Meeting of Stockholders (the 'Grant Date') and the transaction date for the acquisition of RSUs. |
| 2025-05-19 | Date of the signature on the Form 4 filing. |
Keywords
EKSO Bionics, Director, Deborah Lafer Scher, Restricted Stock Units, RSUs, Beneficial Ownership, Form 4, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.